“Safety and Efficacy of Pembrolizumab in Triple Negative Breast Câncer”. Electronic Journal Collection Health 25, no. 6 (June 3, 2025): e20651. Accessed November 3, 2026. https://acervomais.com.br/saude/article/view/20651.